Grant: Master's Award: Canada Graduate Scholarships
McMaster University
$17,500.00
Canadian Institutes of Health Research
EF 2023-24
Résumé
Fibromyalgia is a debilitating musculoskeletal syndrome characterized by chronic pain, fatigue, and various associated symptoms. Its etiology remains unclear, and current treatments often provide limited relief with adverse effects. Repetitive Transcranial Magnetic Stimulation (rTMS) has shown promise by inducing short-term neuroplasticity in the brain. Studies targeting the primary motor cortex (M1) with high-frequency rTMS have demonstrated reduced pain perception in fibromyalgia patients, though findings are inconsistent. Controlled pulse parameter TMS (cTMS) builds upon traditional rTMS, using monophasic pulses that can induce more profound and longer-lasting changes in cortical excitability. The proposed study aims to investigate the effects of a two-week intervention of active versus sham cTMS in individuals with fibromyalgia. Thirty participants will be pseudo-randomized to active or sham cTMS groups, with monophasic pulses delivered over M1 at 10 Hz frequency. The study hypothesizes that active cTMS will lead to improvements in pain, fibromyalgia symptoms, and quality of life compared to sham stimulation. Outcome measures include pain perception, quality of life, fibromyalgia symptoms, patient-perceived change, and emotions towards pain. An ANOVA will analyze pain intensity scores across baseline, post-intervention, and 3 months post-intervention. This innovative treatment protocol aims to disrupt the pain cycle in fibromyalgia, potentially enhancing daily activities and overall quality of life. Success in the active cTMS group could inform future treatment protocols and larger cohort studies. The study also contributes to neuromodulation and pain research by exploring cTMS effects on neuroplasticity and somatosensory function.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
506024
Name
Drapeau Chloe C
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Canadian Institutes of Health Research
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Chronic Pain; Controllable Pulse-Parameter Transcranial Magnet; Fibromyalgia; Inhibition; Motor Cortex; Neuromodulation; Neuroplasticity; Repetitive Transcranial Magnetic Stimulation; Somatosensory Function; Transcranial Magnetic Stimulation
Abstract
Fibromyalgia is a debilitating musculoskeletal syndrome characterized by chronic pain, fatigue, and various associated symptoms. Its etiology remains unclear, and current treatments often provide limited relief with adverse effects. Repetitive Transcranial Magnetic Stimulation (rTMS) has shown promise by inducing short-term neuroplasticity in the brain. Studies targeting the primary motor cortex (M1) with high-frequency rTMS have demonstrated reduced pain perception in fibromyalgia patients, though findings are inconsistent. Controlled pulse parameter TMS (cTMS) builds upon traditional rTMS, using monophasic pulses that can induce more profound and longer-lasting changes in cortical excitability. The proposed study aims to investigate the effects of a two-week intervention of active versus sham cTMS in individuals with fibromyalgia. Thirty participants will be pseudo-randomized to active or sham cTMS groups, with monophasic pulses delivered over M1 at 10 Hz frequency. The study hypothesizes that active cTMS will lead to improvements in pain, fibromyalgia symptoms, and quality of life compared to sham stimulation. Outcome measures include pain perception, quality of life, fibromyalgia symptoms, patient-perceived change, and emotions towards pain. An ANOVA will analyze pain intensity scores across baseline, post-intervention, and 3 months post-intervention. This innovative treatment protocol aims to disrupt the pain cycle in fibromyalgia, potentially enhancing daily activities and overall quality of life. Success in the active cTMS group could inform future treatment protocols and larger cohort studies. The study also contributes to neuromodulation and pain research by exploring cTMS effects on neuroplasticity and somatosensory function.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Drapeau, Chloe C
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~